Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
09/23/2004 | WO2004080965A1 Neuropeptide ff receptor antagonist |
09/23/2004 | WO2004080964A1 Indole derivatives useful for the treatment of diseases |
09/23/2004 | WO2004080963A1 Process for the preparation of indole derivatives by enzymatic acylation |
09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
09/23/2004 | WO2004080455A1 Antibacterial agent and anticancer agent |
09/23/2004 | WO2004080453A1 Antihepatitis c virus agent and anti-hiv agent |
09/23/2004 | WO2004080423A2 7-amino- isoindolyl compounds amd their pharmaceutical uses |
09/23/2004 | WO2004080422A2 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
09/23/2004 | WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use |
09/23/2004 | WO2004080376A2 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease |
09/23/2004 | US20040186301 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
09/23/2004 | US20040186300 Process for the preparation of zafirlukast |
09/23/2004 | US20040186278 2-{5-[1-(5-carboxypentyl)-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene]-3-cyano-1,3-pentadienyl}-1,3,3-trimethyl-3H-indolinium (mesocyano Cy5); for sequencing, microarrays, flow cytometry and proteomics |
09/23/2004 | US20040186160 for treating an abnormal condition associated with protein kinase activity such as cell proliferation, differentiation apoptosis and inhibiting protein kinase signal transduction |
09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
09/23/2004 | US20040186148 E.g., 1-(pyrid-2-yl-so2-),2-((4-(isopropylphenyl)-so2-),5-(isopropoxy)benzene; antiinflammatory agents; immunomodulatory activity rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, multiple sclerosis, diabetes, cancer, glaucoma, osteoporosis, renal ischemia |
09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
09/23/2004 | US20040186125 E.g , 3-cyclohexyl-2-furan-3-yl-1Hindole-5-carboxylic acid; hepatitis C viricides that target RNA dependent RNA polymerases (Ns5B) in mammals, an enzyme essential to viral replication; used in conjunction with an mmunomodulatory agent, such as beta -, delta - gamma -, and omega -interferon |
09/23/2004 | US20040186116 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics |
09/23/2004 | US20040185352 Photothermographic element comprising improved base precursors and methods for their use |
09/23/2004 | US20040185299 Tertiary diamines containing heterocyclic groups and their use in organic electroluminescent devices |
09/23/2004 | DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection |
09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
09/23/2004 | CA2518748A1 Antimicrobial agents and anticancer agents |
09/23/2004 | CA2518584A1 7-amino- isoindolyl compounds and their pharmaceutical uses |
09/23/2004 | CA2518513A1 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses |
09/23/2004 | CA2517569A1 Indole derivatives useful for the treatment of diseases |
09/22/2004 | EP1460064A1 Indole-2-carboxamide derivatives useful as beta-2 agonists |
09/22/2004 | EP1458734A1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer |
09/22/2004 | EP1458721A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino 4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use |
09/22/2004 | EP1458394A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |
09/22/2004 | EP1458385A2 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5 |
09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
09/22/2004 | EP1093455B1 Bis-indole derivatives and their use as antiinflammatory agents |
09/22/2004 | EP0914321B1 Indole derivatives for the treatment of osteoporosis |
09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
09/22/2004 | CN1167422C Quinazoline derivatives as angiogenesis inhibitors |
09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
09/21/2004 | US6794395 Substituted indolinones, their manufacture and their use as medicaments |
09/21/2004 | CA2167673C Condensed benzazepine derivative and pharmaceutical composition thereof |
09/16/2004 | WO2004078988A1 Process for production of aromatic diols |
09/16/2004 | WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library |
09/16/2004 | WO2004078721A1 Processes for producing cyclic benzamidine derivative |
09/16/2004 | WO2004078720A1 Process for the preparation of 1,1,3,3-tetraalkylisoindoline starting from n-benzylphthalimide |
09/16/2004 | WO2004078708A2 Novel method for synthesising derivatives of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro,-ih-indole-2-carboxylic acid and the use thereof for perindopril synthesis |
09/16/2004 | WO2004078707A2 Novel method for synthesising (2s, 3as, 7as)-perhydroindole-2-carboxylic acid and the esters thereof and the use thereof for perindopril synthesis |
09/16/2004 | WO2004078107A2 Novel method for synthesising perindopril and the pharmaceutically acceptable salt thereof |
09/16/2004 | WO2004071445A3 2-(aminomethyl)arylamide analgesics |
09/16/2004 | WO2004069782A3 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
09/16/2004 | WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
09/16/2004 | WO2004056769A3 Synthesis of amines and intermediates for the synthesis thereof |
09/16/2004 | WO2004052855A3 Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
09/16/2004 | WO2004052853A3 Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
09/16/2004 | WO2004050653A3 Oxime ester photoinitiators with heteroaromatic groups |
09/16/2004 | WO2004041781A8 Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones |
09/16/2004 | WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity |
09/16/2004 | US20040181076 Reaction of carbazolone, forrmaldehyde and amine compound in nonaqueous solution and bonding to water, solvent |
09/16/2004 | US20040181075 Process of making chalcone derivatives |
09/16/2004 | US20040181073 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
09/16/2004 | US20040180946 Phenyl-indole compounds for modulating IgE and inhibiting cellular proliferation |
09/16/2004 | US20040180945 in particular, strains of the HIV that have developed cross resistance to other anti-HIV drugs |
09/16/2004 | US20040180923 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
09/16/2004 | US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation |
09/16/2004 | US20040180888 Phenylindoles for the treatment of HIV |
09/16/2004 | US20040180885 Indole derivatives, process for preparation of the same and use thereof |
09/16/2004 | DE10252874A1 New 4-(alkyl, alkenyl or alkynyl)-cyclohexylamine derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain |
09/15/2004 | EP1456185A1 (1.2)-oxazin-3,5-diones |
09/15/2004 | EP1456165A1 Induction of apoptosis in cancer cells |
09/15/2004 | EP1456151A1 Method for forming a carbon-carbon or carbon-heteroatom linkage |
09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
09/15/2004 | EP1194227B1 Preparation and use of ionic liquids in microwave-assisted chemical transformations |
09/15/2004 | EP1141138B1 Phthalimidyl azo pigments, method for producing same and utilisation thereof |
09/15/2004 | EP1140887B1 Phase transfer catalyzed method for preparing oxybisphthalic compounds |
09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
09/15/2004 | CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
09/15/2004 | CN1166659C Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites |
09/15/2004 | CN1166638C Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same |
09/15/2004 | CN1166637C Antibacterial activity, induction, separation and synthesis of N-acyltryptamine derivative as plant protecting chemical |
09/15/2004 | CN1166636C Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
09/15/2004 | CN1166403C Multicatalytic protease inhibitors |
09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
09/14/2004 | US6790963 E-isomeric fullerene derivatives |
09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
09/14/2004 | US6790848 4-piperazinylindole derivatives with 5-HT6 receptor affinity |
09/14/2004 | CA2264549C Spirocyclic dopamine receptor subtype ligands |
09/10/2004 | WO2004076457A1 Solvent-free process for the preparation of pyrrolo (3,4c) pyrrole compounds |
09/10/2004 | WO2004076456A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
09/10/2004 | WO2004076417A1 Novel crystalline forms of trandolapril |
09/10/2004 | WO2004075895A1 Ocular hypotensive agent |
09/10/2004 | WO2004075889A1 Process for preparation of perindopril and salts thereof |
09/10/2004 | WO2004075847A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS |
09/10/2004 | WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes |